Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Senator Adam Schiff tells TIME Democrats plan to bring the Senate chamber to a halt in the coming days by Nik Popli by Philip Elliott Yuri Gripas—Abaca/Bloomberg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results